Flash movie failed to load.

 News Releases
ValveXchange receives $1.6 million from NIH to develop next generation product.

ValveXchange, Inc.
12635 East Montview Blvd.
Aurora, CO 80010-7335
303-648-4077
888-822-8998 (toll free)
888-308-3553 (fax)
info@valvexchange.com

Notice: ValveXchange, Inc. products have not been approved by the U.S. FDA or any other Regulatory Agencies. This website contains forward looking statements which represent management's best judgment, but are speculative and may not occur as projected or not at all.



ValveXchange Inc. ("VXi") is dedicated to improving the lives of patients requiring heart valve replacements. VXi holds patented technology on a two-piece bioprosthetic tissue valve that resolves the long standing compromises between conventional mechanical and tissue heart valves. The VXi technology is being designed to be easily adopted by surgeons and provide optimal patient benefits.


The VXi System consists of a two-piece valve and the associated tools for replacing the exchangeable component. The permanent component is a surgically-implantable support frame... [read more]

Physicians who are interested in keeping in touch with company VXi Heart Valve System developments... [read more]